Leibovich 2018 histology-specific RCC models after surgery
Leibovich 2018 histology-specific RCC models after surgery. Required histology clear_cell, papillary, or chromophobe. ccRCC PFS points (2010 TNM): t1a/t1b/t2a 0, t2b 2, t3a-t3c 3, t4 4; nx/n0 0, n1 2; size ≥10 cm 1; grade 1-2 0, 3 1, 4 3; necrosis 2; max 12;…
by api.magentlab.com · discovered, not yet claimed by its owner · updated 2026-10-13
Mirrored from Coinbase's public x402 Bazaar. The description is the provider's own text and has not been reviewed here; the payment requirements are copied as published.
What it does
Leibovich 2018 histology-specific RCC models after surgery. Required histology clear_cell, papillary, or chromophobe. ccRCC PFS points (2010 TNM): t1a/t1b/t2a 0, t2b 2, t3a-t3c 3, t4 4; nx/n0 0, n1 2; size ≥10 cm 1; grade 1-2 0, 3 1, 4 3; necrosis 2; max 12; risk low 0-2, intermediate 3-5, high ≥6. Papillary and chromophobe return the 2018 three PFS groups (score 0-2). Not SSIGN. Not Leibovich 2003. magent does not stage or read pathology. Not a diagnosis. Not a medical device.
Tags: leibovich-2018 · rcc · kidney · prognosis · calculator · bazaar
Call contract
- Method
- POST
- Input
- HTTP request
- Output
- json
- Last paid call
- 2026-10-13
{
"items": [
{
"histology": "clear_cell",
"n_stage": "n0",
"necrosis": false,
"nuclear_grade": 2,
"t_stage": "t1a",
"tumor_size_cm": 3
},
{
"histology": "clear_cell",
"n_stage": "n0",
"necrosis": false,
"nuclear_grade": 2,
"t_stage": "t1a",
"tumor_size_cm": 3
}
]
}{
"count": 2,
"items": [
{
"citation": {
"authors": "Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP",
"doi": "10.1016/j.eururo.2018.01.005",
"id": "leibovich-2018",
"pmid": "29398265",
"source": "Eur Urol. 2018;73(5):772-780",
"title": "Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery"
},
"components": [
{
"factor": "t_stage",
"points": 0,
"present": true,
"value": "t1a"
},
{
"factor": "n_stage",
"points": 0,
"present": true,
"value": "n0"
},
{
"factor": "tumor_size_cm",
"points": 0,
"present": false,
"value": 3
},
{
"factor": "nuclear_grade",
"points": 0,
"present": true,
"value": 2
},
{
"factor": "necrosis",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula": "leibovich_2018",
"formula_expression": "ccRCC PFS (Leibovich 2018, 2010 TNM): t_stage (t1a/t1b/t2a 0, t2b 2, t3a/t3b/t3c 3, t4 4) + n_stage (nx/n0 0, n1 2) + tumor_size_cm >=10 1 + nuclear_grade (1-2 0, 3 1, 4 3) + necrosis 2; max 12; risk low 0-2, intermediate 3-5, high >=6. papillary PFS groups: low grade 1-2 and t1-t2; intermediate grade 3 and t1-t2; high grade 4 or t3a-t4 (fat or thrombus). chromophobe PFS groups: low t1-t2 and nx/n0; intermediate t3a-t4 and nx/n0 (fat); high n1. Not Frank 2002 SSIGN. Not Leibovich 2003. No chromophobe CSS model.",
"histology": "clear_cell",
"max_score": 12,
"n_stage": "n0",
"necrosis": false,
"nuclear_grade": 2,
"risk": "low",
"score": 0,
"t_stage": "t1a",
"tumor_size_cm": 3
},
{
"citation": {
"authors": "Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP",
"doi": "10.1016/j.eururo.2018.01.005",
"id": "leibovich-2018",
"pmid": "29398265",
"source": "Eur Urol. 2018;73(5):772-780",
"title": "Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery"
},
"components": [
{
"factor": "t_stage",
"points": 0,
"present": true,
"value": "t1a"
},
{
"factor": "n_stage",
"points": 0,
"present": true,
"value": "n0"
},
{
"factor": "tumor_size_cm",
"points": 0,
"present": false,
"value": 3
},
{
"factor": "nuclear_grade",
"points": 0,
"present": true,
"value": 2
},
{
"factor": "necrosis",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula": "leibovich_2018",
"formula_expression": "ccRCC PFS (Leibovich 2018, 2010 TNM): t_stage (t1a/t1b/t2a 0, t2b 2, t3a/t3b/t3c 3, t4 4) + n_stage (nx/n0 0, n1 2) + tumor_size_cm >=10 1 + nuclear_grade (1-2 0, 3 1, 4 3) + necrosis 2; max 12; risk low 0-2, intermediate 3-5, high >=6. papillary PFS groups: low grade 1-2 and t1-t2; intermediate grade 3 and t1-t2; high grade 4 or t3a-t4 (fat or thrombus). chromophobe PFS groups: low t1-t2 and nx/n0; intermediate t3a-t4 and nx/n0 (fat); high n1. Not Frank 2002 SSIGN. Not Leibovich 2003. No chromophobe CSS model.",
"histology": "clear_cell",
"max_score": 12,
"n_stage": "n0",
"necrosis": false,
"nuclear_grade": 2,
"risk": "low",
"score": 0,
"t_stage": "t1a",
"tumor_size_cm": 3
}
],
"path": "/api/calc/leibovich_2018"
}Use with an agent
- Discover. Agents find this listing with
GET https://bazaar.saylorinnovations.com/discovery/search?query=…, the MCP toolsearch_resources, or/discovery/resources. - Inspect. Fetch
/resources/39059.jsonfor the price and payment options. - Pay. Call
GET https://api.magentlab.com/api/calc/leibovich_2018. The provider answers402with its payment requirements. An x402 client signs one of the options below and retries withPAYMENT-SIGNATURE. - Execute. The provider returns
200with the data. Agent Bazaar is not in the request path and never sees your payment.
For humans
You don't need an account or an API key; you need a wallet holding a small amount of USDC on Base, and an x402-capable client (see the examples below). Call the endpoint unpaid first to see exactly what it asks for.
Pricing & payment
- Price
- $0.005 / request
- Protocol
- x402 v2
- Auth
- No account or API key. Pay per request.
- Networks
- Base
- Demand
- 5 calls · 2 unique payers in 30d (public x402 Bazaar data)
x402 payment requirements
| Scheme | Network | Asset | Amount | Pay to | Timeout |
|---|---|---|---|---|---|
| exact | Base eip155:8453 | USDC | $0.005 | 0x836Be278f1739fB4308091cD1852F7971Bc19Ee2 | 600s |
accepts[] (raw JSON)
[
{
"scheme": "exact",
"network": "eip155:8453",
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"amount": "5000",
"amountUsd": 0.005,
"maxTimeoutSeconds": 600
}
]Schemas
Output schema (JSON Schema)
{
"properties": {
"example": {
"type": "object"
},
"type": {
"type": "string"
}
},
"required": [
"type"
],
"type": "object"
}Example shape — generated from the schema, not a captured live response
{
"example": {},
"type": "string"
}Examples
curl "https://api.magentlab.com/api/calc/leibovich_2018"
# -> 402 Payment Required, accepts[] lists how to pay
# retry with a PAYMENT-SIGNATURE (or PAYMENT header) once paidconst res = await fetch("https://api.magentlab.com/api/calc/leibovich_2018");
if (res.status === 402) {
const { accepts } = await res.json();
// pay one of accepts[] via an x402 client, then retry with the payment header
}import httpx
res = httpx.get("https://api.magentlab.com/api/calc/leibovich_2018")
if res.status_code == 402:
accepts = res.json()["accepts"]
# pay one of accepts[] via an x402 client, then retry with the payment headerDetails
- Provider
- api.magentlab.com
- Endpoint
- https://api.magentlab.com/api/calc/leibovich_2018
- Machine-readable
/resources/39059.json